维亚生物(01873.HK) 公布，全资附属杭州维亚宗晨与南京瑞弘、南京高质量等多间公司订立合伙协议，共同成立基金。杭州维亚宗晨将于该基金投资2,500万元人民币(下同)，而基金总资本为3亿元。
集团指，基金主要从事私募股权投资、投资及资产管理，并主要聚焦医药行业内的早期开发项目，重点关注生命科学领域的前沿技术创新及转化。(ss/da)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.